Trademark Search  /  CELLJUVANT STUDY CELL-BASED ADJUVANT TECHNOLOGY

CELLJUVANT STUDY CELL-BASED ADJUVANT TECHNOLOGY

● Live · Pending

U.S. federal trademark · Serial No. 97263760

Mark
CELLJUVANT STUDY CELL-BASED ADJUVANT TECHNOLOGY
Status
Pending
Serial Number
97263760
Filing Date
February 11, 2022
Class(es)
Class 042, Class 044

Owners

Seqirus Inc.
03 · Holly Springs, NC, US
Seqirus Inc.
03 · Holly Springs, NC, US

Goods & Services

Scientific research in the nature of conducting clinical trials for pharmaceutical preparations; scientific research in the nature of conducting clinical trials for flu vaccines; providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development

Medical information; pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "CELLJUVANT STUDY CELL-BASED ADJUVANT TECHNOLOGY" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.